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Canonical RNA processing in mammalian mitochondria is deﬁned by tRNAs
acting as recognition sites for nucleases to release ﬂanking transcripts. The
relevant factors, their structures, and mechanism are well described, but not
all mitochondrial transcripts are punctuated by tRNAs, and their mode of
processing has remained unsolved. Using Drosophila and mouse models, we
demonstrate that non-canonical processing results in the formation of 3′
phosphates, and that phosphatase activity by the carbon catabolite repressor
4 domain-containing family member ANGEL2 is required for their hydrolysis.
Furthermore, our data suggest that members of the FAST kinase domaincontaining protein family are responsible for these 3′ phosphates. Our results
therefore propose a mechanism for non-canonical RNA processing in
metazoan mitochondria, by identifying the role of ANGEL2.

Transcription of the mammalian mitochondrial genome (mtDNA) is
initiated from two designated promoter regions, which generate long,
primary polycistronic transcripts that cover almost the entire length of
the mtDNA molecule1. The mitochondrial tRNA punctuation model,
proposed 40 years ago, deﬁnes that tRNAs intersperse the mitochondrial genome and act as excision sites to release the individual
transcripts prior to maturation2. Since then, the responsible ribonucleases RNase P and ELAC2 and their mechanistic and structural basis
have been described3–9. Mammalian mtDNA encodes for 2 rRNA, 22
tRNAs and 11 mRNAs, and this model explains processing of most

transcripts in metazoan mitochondria7,9–13. However, in mammals at
least two gene junctions do not follow this canonical pattern, and the
mechanism of their processing has remained mainly unknown. Several
members of the FAST kinase domain containing protein family have
been associated with cleavage of such junctions14–17. Speciﬁcally,
FASTKD4 and FASTKD5 have been implicated in the maturation of
transcripts lacking ﬂanking tRNAs, but the mechanism is unclear18.
After excision, the individual transcripts are further modiﬁed by
polyadenylation of most mRNAs by the mitochondrial polynucleotide
adenylyltransferase MTPAP19–22, and methylation and pseudouridylation
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of mitochondrial tRNAs and rRNAs23–35. While the mechanisms of transcription, processing, and translation are increasingly understood36,37,
the role of polyadenylation inside mitochondria is less clear, and has
been proposed to act as both degradation and stabilisation signal20.
Several factors have been shown to directly affect MTPAP activity and
polyadenylation. For instance, the polynucleotide phosphorylase,
PNPase, and the ATP-dependent RNA helicase SUV3 have been shown to
inversely regulate poly(A) tail length via MTPAP38–44. Furthermore, the
leucine rich pentatricopeptide repeat containing protein, LRPPRC, stabilises mitochondrial mRNAs and stimulates MTPAP activity41,45,46.
While several mitochondrial transcripts require polyadenylation
to complete their translational stop codons, mt:Nd6 is the only mRNA
not polyadenylated in humans or mouse for yet unknown reasons20.
The role of the poly(A) tail in translation is not clear, but we previously
demonstrated that transcripts lacking a poly(A) signal can still be
translated but lose their 3′ integrity21. Previous studies revealed that
polyadenylation occurs prior to full partitioning of the primary
transcripts10,47, necessitating a deadenylase to remove such tails from
immature tRNAs prior to maturation, and although a PNPase/SUV3
complex has been shown to degrade mRNAs38–42, their role in deadenylation is not clear. In mitochondria only the carbon catabolite
repression 4 (Ccr4) family member, 2’,5’-phosphodiesterase, PDE12,
has been proposed to have deadenylation function48–50, capable of
removing spurious poly(A) additions on selected mitochondrial
tRNAs50. But whether additional deadenylases function within mitochondria is unknown.
Here, we identify that ANGEL2 and its Drosophila homologue,
DmAngel, are mitochondrial proteins that are essential during noncanonical processing. Using Drosophila and mouse knock out models,
we demonstrate that upon loss of DmANGEL or ANGEL2, transcripts
that undergo non-canonical processing, accumulate 3’ phosphates,
preventing their polyadenylation, causing a respiratory chain deﬁciency. Through immunoprecipitation experiments, we show that
DmAngel interacts with a member of the FASTK protein family, and its
deletion prevents cleavage during non-canonical processing. Our
results describe the mechanism of non-canonical processing and
identify the formation of terminal phosphates as an important
intermediary step.
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this by expressing C-terminally tagged GFP-fusion proteins in human
ﬁbroblasts (Fig. 1a), and subcellular fractionation experiments (Fig. 1b
and Supplementary Fig. 1c). We next performed proteinase K, swelling,
and sodium carbonate treatments to determine both submitochondrial localisation and membrane association of HsANGEL1,
HsANGEL2, and DmANGEL (Supplementary Fig. 1d, e). Together, our
results are consistent with an outer mitochondrial membrane localisation of ANGEL1, while ANGEL2 and DmANGEL localise to the mitochondrial matrix (Fig. 1c), suggesting a functional homology between
ANGEL2 and DmANGEL.

Deletion of DmAngel in ﬂies and ANGEL2 in mice causes
respiratory chain deﬁciency
To understand their physiological roles in the mitochondrial matrix,
we studied CRISPR/Cas9 knockout models in both ﬂy (DmAngelKO) and
mouse (MmAngel2KO) (Supplementary Fig. 2a–d). Loss of DmANGEL
resulted in a lethal phenotype during the pupal stage, with no homozygous KO ﬂies hatching (Supplementary Fig. 2e). Correct targeting
was conﬁrmed by expressing a DmAngel transgene (DmAngelRescue) with
or without a FLAG-tag in the DmAngelKO background, rescuing the
lethal phenotype (Supplementary Fig. 2f–h). Furthermore, expression
of a transgene encoding a catalytically dead mutant DmANGEL protein
(DmAngelE121A)48 failed to rescue the DmAngelKO phenotype, validating
that DmANGEL activity is necessary for normal ﬂy development (Supplementary Fig. 2h). Deletion of Angel2 in mice (MmAngel2KO) resulted
in viable offspring at Mendelian proportions, without any obvious
phenotype until 15 months of age, when we stopped observing the
animals.
We next measured mitochondrial respiratory chain enzyme
activities, and DmAngelKO larvae presented with a mitochondrial dysfunction in complexes I, IV and V (Fig. 1d and Supplementary Fig. 2i),
while an isolated complex I deﬁciency was observed in heart mitochondria from 16-week-old MmAngel2KO mice (Fig. 1e and Supplementary Fig. 2j). Untargeted proteomic analysis in DmAngelKO larvae
(Fig. 1f and Supplementary Data File 1) and MmAngel2KO hearts (Fig. 1g
and Supplementary Fig. 2k and Supplementary Data File 1) conﬁrmed
that the mitochondrial dysfunction most likely is caused by reduced
OXPHOS subunit levels. Together, these results suggest that DmANGEL and ANGEL2 have a role in mitochondrial gene expression.

Results
CCR4-family Angel proteins share evolutionary history with the
deadenylase PDE12 and are localised to mitochondria

Hydrolysis of 3′ terminal phosphates by DmANGEL and ANGEL2
is required during non-canonical processing

We set out to identify additional factors involved in the deadenylation
of mitochondrial transcripts and thus performed a biological pathway
analysis based on evolutionary deduction51, using both MTPAP and
PDE12 as bait. While MTPAP returned no candidates, PDE12 was coevolutionarily absent with other Ccr4 family members in some amoeba
and protozoa (Supplementary Fig. 1a). All three factors carry an
endonuclease/exonuclease/phosphatase domain (PFAM: PF03372),
thought to be involved in the removal of the polyadenylation signal of
mRNAs due to its strong conservation among known deadenylases52.
CCR4C, also known as Nocturnin (NOCT) affects cytosolic poly(A) tail
dynamics during the circadian rhythm in mice53 and recently has been
linked to inter-conversion of the dinucleotides NADP+/NADPH and
NAD+/NADH54. The paralogs CCR4E and CCR4D, also known as ANGEL1
and 2, resulted from a gene duplication in the vertebrate lineage with
only a single ANGEL homologue present in Drosophila (CG12273)55,56.
ANGEL1 has previously been described to localise to the endoplasmic
reticulum and/or Golgi apparatus and interact with the translation
initiation factor 4E, eIF4E57, while ANGEL2 has recently been shown to
hydrolyse terminal 2′,3′-cyclic phosphates (2′,3′cP) on RNA molecules
in vitro58.
In silico prediction models suggested a mitochondrial localisation
for both human ANGELs (HsANGEL1 and HsANGEL2), as well as for
Drosophila ANGEL (DmANGEL) (Supplementary Fig. 1b). We conﬁrmed

We measured mRNA steady-state levels in both models, revealing that
mt:Atp8/6 and mt:Nd5 in mouse and mt:nd5, mt:atp8/6-mt:co3 and
mt:nd6-mt:cytb in ﬂy (Fig. 2a–g and Supplementary Fig. 3a–c) were
signiﬁcantly upregulated, while mt:tRNA levels were mostly unchanged in both model systems (Supplementary Fig. 3d–i). An exception
are mt:tRNACys and mt:tRNATyr in Drosophila, which were both signiﬁcantly reduced. Notably, while the gene content of the Drosophila
and mammalian mtDNA is identical, the gene order differs (Fig. 2d, h)
and the affected messenger transcripts all require non-canonical processing (i.e. not separated by tRNAs) in MmAngel2KO or DmAngelKO
samples, with the exception of mt:nd5 in ﬂy (Fig. 2e–g). Furthermore,
Northern blot analysis revealed that the mt:Atp8/6 transcript migrated
slightly faster in MmAngel2KO samples, in comparison to controls
(Fig. 2a). We therefore measured mitochondrial poly(A) tail length
(MPAT) (see materials and methods). Most transcripts showed a normal polyadenylation pattern in hearts of 16-week-old MmAngel2KO mice
and DmAngelKO larvae (Fig. 3a, b and Supplementary Fig. 4a, b). In
contrast, mt:Nd5 and mt:Atp8/6 in mouse, and mt:nd6 and mt:atp8/6
transcripts in ﬂy presented with a reduced polyadenylation pattern in
MmAngel2KO and DmAngelKO samples, respectively (Fig. 3a, b).
We argued that since the 3′ ends of these transcripts undergo noncanonical processing, DmANGEL and mammalian ANGEL2 could partake in their polyadenylation. Polyadenylation requires a 3′ hydroxyl to
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ligate incoming adenosine residues to the terminal residue, and
nucleases usually hydrolyse phosphodiester bonds to retain a free 3′
OH. However, for some ribonucleases the scissile bond is downstream
of the phosphorus atom, resulting in a 3′ phosphate end and a free 5′
hydroxyl upon cleavage. Additionally, free 2′ phosphates or 2′,3′-cPs
have also been reported59. The MPAT assay relies on ligating primers to
the 3′ end of the transcripts prior to ampliﬁcation and separation on
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(Supplementary Fig. 4c). Both treatments revealed large amounts of
3

Article

https://doi.org/10.1038/s41467-022-33368-9
oxidoreductase (CII), succinate: cytochrome c oxidoreductase (CII + III), and cytochrome c oxidase (CIV), in isolated mitochondria from (d) 4-days-after-egg-laying
(dael) DmANGEL KO (red; DmAngel KO1,2) and control (light grey; wDah) larvae, and
(e) 16-week-old mouse hearts (blue; Angel2 KO) and controls (light grey; Angel2
WT). (Data in d, e are represented as mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.001
with two-tailed Student’s t test; Dm n = 5, Mm wt n = 4, Mm KO n = 3 biologically
independent samples). f Proteomic levels of individual subunits of the ﬁve OXPHOS
complexes, accessory, and OXPHOS assembly factors in 4-dael DmAngelKO larvae.
Data are presented as 25 to 75 percentile box with median, and whiskers represent
±1.5× inter-quartile range (n = 4 biologically independent samples). No statistical
test was performed. g Gene set enrichment analysis of proteomic data in 16-weekold mouse hearts, relative to controls. p values are given as false discovery rates
after multiple testing adjustment (n = 3 biologically independent samples).
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non-polyadenylated 3′ termini on mt:Nd5 and mt:Atp8/6 in MmAngel2KO
mice, and mt:nd6 and mt:atp8/6 in DmAngelKO larvae, due to the presence of a terminal phosphate group (Fig. 3a, b, -℗). In contrast, their
downstream transcripts mt:Cytb and mt:Co3, showed normal polyadenylation with no effect of CIP or PNK treatment. The same observations were made in liver, skeletal muscle, and kidney samples of
MmAngel2KO mice, suggesting that ANGEL2 activity is ubiquitous
(Supplementary Fig. 5a–c).
Ligation of an RNA linker using RtcB ligase, which requires free 3′
phosphates or 2′,3′-cP, followed by MPAT, further conﬁrmed the presence of 3′ phosphates on mt:Nd5 and mt:Atp6 in mouse and mt:nd6
and mt:atp8/6 in ﬂy (Fig. 4a, b). Our results therefore suggest that
ANGEL2 and DmANGEL hydrolyse 3′ phosphates formed during non-

canonical processing in vivo. To conﬁrm phosphatase activity and to
demonstrate that DmANGEL and MmANGEL are indeed orthologs, we
incubated recombinant DmANGEL and an N-terminally truncated
MmANGEL2 with oligonucleotides containing 2′-, 3′-, or 2′,3′-cPs. In
agreement with observations made with human ANGEL258, both
ANGEL homologues efﬁciently hydrolysed 2′- or 2′,3′-cPs, but not 3′
phosphates in vitro (Fig. 4c). This discrepancy with our in vivo data
suggests DmANGEL/ANGEL2 activity differs in vivo, or that the physiological conditions in the absence of the ANGEL homologues favour
3′ phosphate formation after cleavage.
CIP or PNK treatment also revealed a prominent pool of nonpolyadenylated transcripts for mouse mt:Co1 transcripts independent
of MmANGEL2 (Fig. 3a). Murine mt:Co1 contains a short 3′ UTR
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Fig. 4 | ANGEL2 and DmANGEL are terminal phosphatases in vivo and in vitro.
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presence of RNA oligos (20 nts) containing 3′-, 2′-, or 2′,3′-cPs as indicated. PNK
treatment was used as positive control. Representative experiments are shown of at
least two independent experiments performed with biologically independent
samples.

corresponding to anti-tRNASer1 and has previously been considered to
undergo non-canonical processing at its 5′ end14,15. Additionally, a nonpolyadenylated pool of mt:Co1 transcripts has previously been
observed60. We tested whether the other member of the CCR4 family,
NOCT, was involved in de-phosphorylation of mt:Co1. NOCT has
recently been suggested to have a mitochondrial-localised isoform54,
but we observed no difference in polyadenylation or 3′ phosphate
status in samples from NOCT KO mice61 (Supplementary Fig. 6a).
Finally, mammalian mt:Nd6 is the only mitochondrial mRNA not
polyadenylated and has been reported to be notoriously difﬁcult to
clone20. However, our MPAT analysis does not support that a free 3′
phosphate prevents mt:Nd6 polyadenylation (Fig. 3a), and maps its 3′
end to position +1147, with a weaker signal at +1148. In contrast, we did
observe a weak oligoadenylation signal, which we conﬁrmed by
sequencing (Supplementary Fig. 6b), suggesting that some mt:Nd6
transcripts indeed have short poly(A) tails.

(Fig. 5c and Supplementary Fig. 8b, c). This suggests that loss of
DmAngel alters the translation efﬁciency of speciﬁc mRNAs. Additionally, we found a signiﬁcant reduction of mt:tRNAMet associated with
the translating mitoribosome in DmAngelKO larvae, consistent with
stalling, rather than increased translation initiation (Fig. 5d). Coverage
analysis of the mitoribosomal footprints along mt:atp6 mRNA revealed
increased reads corresponding to the 3′ end of the mRNA and lack of
polyadenylation required to complete the STOP codon in DmAngelKO
larvae, implying stalling of the ribosome (Supplementary Fig. 8c, d). In
contrast, the 3′ end of mt:nd6 was not over-represented in knockout
samples, consistent with the presence of a complete STOP codon, and
normal release from the mitoribosome.

Loss of Angel affects mitochondrial translation and the translatome composition
The absence of polyadenylation results in an mt:Atp6 transcript lacking
a complete translational stop codon20. We also observed a mild effect
on de novo translation in heart and liver mitochondria from 16-weekold MmAngelKO mice with ND5 slightly upregulated, probably due to
the increased mt:Nd5 transcript levels (Supplementary Fig. 7). In contrast, DmAngelKO larvae had a more aberrant translation pattern
(Fig. 5a), consistent with the different severity observed in mouse and
ﬂy. Sucrose density fractionations of mitochondrial lysates revealed
increased mitochondrial monosome formation in the absence of
DmANGEL (Fig. 5b and Supplementary Fig. 8a), suggesting either
increased translation or stalling. Mitoribosome proﬁling62 revealed
increased association of mt:cytb mRNA with the translating mitoribosome, and reduced association with mt:co1, mt:co3 and mt:nd3 mRNAs
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DmAngel is part of the processing machinery of non-canonical
transcripts
Finally, we performed immunoprecipitation (IP) experiments in combination with stable-isotope labelling of amino acids in fruit ﬂies
(SILAF)63 to identify factors interacting with DmANGEL. With massspectrometry-based proteomics we identiﬁed, among others, enrichment for CG13850, a mitochondrial protein of unknown function
(Fig. 6a and Supplementary Fig. 9a and Supplementary Data File 1). We
conﬁrmed this interaction in a reciprocal IP, using ﬂies expressing a
CG13850-FLAG tag fusion protein (Fig. 6b and Supplementary Data
File 1). A homology search identiﬁed CG13850 as a homologue of the
mammalian FAS-activated serine/threonine kinase domain-containing
protein family (FASTK). Unlike humans, who encode 6 different FASTK
proteins (FASTK, and FASTKD1 to 5)18, Drosophila contain only two
homologues, and CG13850 most closely aligns with human FASTKD4
(Fig. 6c), which is supported by its interaction with ANGEL2 in a recent
mitochondrial proximity study64. Silencing of CG13850 in ﬂies speciﬁcally affected the processing of the non-canonical junctions at mt:atp8/
6–mt:co3 and mt:nd6–mt:cytb (Fig. 6d), strongly supporting the notion
6
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Fig. 5 | Incomplete non-canonical processing due to loss of DmANGEL results in
aberrant mitochondrial translation. a De novo translation in isolated mitochondria from 4-dael control (wDah) and DmAngelKO (KO 1,2) larvae. Mitochondrial
proteins are indicated. Porin was used as loading control. A representative
experiment is shown with n = 2 biologically independent samples, of two independent experiments performed. b Western blots of ribosome gradient fractions
from 4-dael control and DmAngelKO larvae, decorated with antibodies against the

small (MRPS16) and large (MRPL12) mitochondrial ribosome subunits. The small
(28S), large (39S), and monosome (55S) fractions are indicated. A representative
experiment is shown of four independent experiments performed with biologically
independent samples. c, d Abundance of mitoribosome footprints in mitochondrial
transcripts from ribosome proﬁling experiments in control and DmAngelKO as
indicated, normalised to total read count and expressed as proportion of total
footprints (n = 2 biologically independent samples).

that CG13850, and its mammalian homologues FASTKD4 and 5, are
responsible for processing of non-canonical junctions. Additionally,
knockdown of CG13580 resulted in reduced mRNA steady-state levels
(Supplementary Fig. 9b, c), aberrant mitochondrial translation (Supplementary Fig. 9d), and compromised OXPHOS activity (Fig. 6e),
strongly supporting that CG13850 is the Drosophila ortholog of
members of the FASTK family.

In contrast, we here demonstrate that ANGEL2 and DmANGEL
localise to the mitochondrial matrix, which is in agreement with previous large-scale subcellular proteomic studies64,69,70. Furthermore, we
establish that unlike NOC, ANGEL2 and DmANGEL hydrolyse terminal
phosphates formed during non-canonical processing. While our in vivo
results suggest that non-canonical processing results in 3′ terminal
phosphates, experiments using recombinant proteins conﬁrm previous observations that ANGEL2 and DmANGEL preferentially hydrolyse 2′- or 2′,3′-cPs in vitro58. Whether cleavage in vivo results in 2′,3′cPs, which are successively converted to 3′-P in the absence of
DmANGEL/ANGEL2, or whether the in vivo activity for DmANGEL/
ANGEL2 differs, will require further investigation.
Loss of DmANGEL is larvae lethal, while MmAngel2KO mice are
viable, which might be explained by the reduced gene content of the
Drosophila genome. While Drosophila have only two FASTK homologues, mammals encode 6 different FASTK family members, previously associated with various roles in the post-transcriptional
regulation of mitochondrial gene expression15–18. All FASTK family
members contain a C terminal RAP (RNA binding domain abundant in
Apicomplexans) domain that has been suggested to fold into a PD-(D/
E)-XK nuclease superfamily fold16,18, and several studies have linked
FASTKD4 and FASTKD5 to non-canonical processing14–17. Our results
suggest that during non-canonical processing FAST kinases cleave the
phosphodiester bond downstream of the bridging phosphorus atom,
resulting in free 3′ phosphates and 5′ hydroxyls. This mechanism also
fully explains the previous observation that the majority of mt:Co3
transcripts, which is downstream of mt:Atp8/6, contain a 5′ hydroxyl
group instead of a monophosphate71. In the absence of ANGEL2, the 3′
phosphate groups are retained and transcripts resulting from noncanonical processing cannot proceed to polyadenylation, resulting, in
the case of ATP6, in an incomplete STOP codon. It is thus feasible to
suggest that DmANGEL and its interactor CG13850 are required for
additional functions in the ﬂy, resulting in the lethal phenotype.
Interestingly, loss of DmANGEL also affected mt:tRNACys and mt:tRNATyr

Discussion
The mitochondrial tRNA punctuation model was proposed 40 years
ago and deﬁnes the canonical mode of RNA processing, where tRNAs
intersperse the mitochondrial genome and act as excision sites to
release the individual transcripts prior to maturation2. In contrast, noncanonical processing describes the release of transcripts not ﬂanked
by tRNAs, but its mechanism is largely unknown. Here we demonstrate
that cleavage of such junctions results in unconventional terminal
phosphates, requiring phosphatase activity by ANGEL2 in mammals
and DmANGEL in Drosophila melanogaster prior to polyadenylation.
Using ﬂy and mouse KO models, as well as recombinant DmANGEL and
ANGEL2, we establish that DmANGEL is the Drosophila ortholog of
ANGEL2. Interaction studies with DmANGEL further suggest that noncanonical processing requires members of the FASTK family, which
most likely, are responsible for cleavage.
ANGEL2 has previously been suggested to localise to the nucleus,
where it forms a deadenylase complex together with hCaf1z (also
known as TOE1) in the nuclear Cajal bodies65 or interact with p21 to
control the cell cycle66. However, these studies used N-terminally
tagged fusion constructs, which interfere with the mitochondrial
localisation signal, directing the fusion protein to the wrong cellular
compartment. In agreement, neither deadenylation activity nor TOE1
interaction could be conﬁrmed in later studies58,67,68. Likewise, we
failed to observe any link to the cellular UPR in the proteome of mice
deﬁcient of ANGEL2 (Fig. 1g and Supplementary Fig. 2k) as previously
proposed58.
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Fig. 6 | Members of the FASTK family are required for non-canonical processing
of mitochondrial transcripts. a Volcano plot of proteomics data from immunoprecipitation (IP) experiments, using 4 dael larvae from DmANGEL-FLAG versus
DmANGEL overexpressing larvae (n = 4). Proteins in the category “mitochondria”
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and CG31643 are the two Drosophila FASTK family orthologs. d Northern blot
analysis of selected mitochondrial transcripts in 4-dael control (daGAL4 and RNAi)
larvae and larvae with silenced CG13850 (CG13850 RNAi). RP49 was used as loading
control. Representative experiment is shown with n = 2 biologically independent
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steady-state levels, which we previously observed in other ﬂy models
affecting mitochondrial gene expression21,41, and which might additionally affect mitochondrial translation. However, the impact on
translation, especially in mice, is mild, suggesting that even in the
absence of a STOP codon and poly(A) tail, sufﬁcient translation can still
occur. This agrees with our previous observation that in the absence of
mitochondrial polyadenylation, translation is retained, but mRNA
integrity is compromised21.
The role of polyadenylation of mitochondrial transcripts is not
fully understood, although oligoadenylation, i.e. the addition of only a
few adenine residues, is required to complete several translational
stop codons20. Interestingly, we observed substantial differences in
poly(A) tail length of several transcripts in kidney and liver, versus
heart and muscle mitochondria. The reason for this difference
between tissues is not clear to us but might expose additional functions of the poly(A) tail in mitochondrial gene expression.

Together, our results are in full agreement with the notion that
ANGEL2 is responsible for the dephosphorylation of the 3′ ends of
mitochondrial transcripts and deﬁnes a fundamental step of noncanonical processing in mitochondria (Fig. 7).
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Methods
Generation of a DmAngel knock-out line
The generation of the DmAngel knock-out lines (DmAngelKO#1 and
DmAngelKO#2) was performed as previously described72. The sequence
of the DmAngel gene, obtained from sequencing genomic DNA from
the ﬂy line nos-Cas9 (Bloomington Stock #54591), was entered into
CRISPR Optimal Target Finder (http://targetﬁnder.ﬂycrispr.neuro.
brown.edu) and the target sites with the lowest off-target score were
selected (GCAGATTTCTTTCCTCCACTCGG and GGTTGTCTCATAT
AACATCCTGG). The gRNAs were cloned into BbsI digested pCFD4
(Addgene plasmid #49411) by Gibson assembly, as detailed in72.
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Fig. 7 | ANGEL2 phosphatase activity is required for the maturation of mRNAs
that undergo non-canonical processing. Model of the non-canonical processing
of mitochondrial RNA. The mitochondrial RNA polymerase, POLRMT, transcribes
long, polycistronic transcripts, which are cleaved by RNase P and ELAC2 at the tRNA

gene junctions. Non-canonical junctions are recognised by members of the FASTK
family (FASTK*), resulting in the formation of 3′ phosphates. Phosphatase activity
by ANGEL2 hydrolyses the 3′ ends of mt:Nd5 and mt:Atp8/6, allowing further their
polyadenylation by the mitochondrial poly(A) polymerase, MTPAP.

Primers used to generate the constructs are detailed in Supplementary
Data File 2. The pCFD4 plasmid containing the gRNAs was used to
generate a gRNA expressing ﬂy line, using BestGene Inc
(California, USA).
Males carrying the gRNAs were crossed to virgin nos-Cas9 females
for germline-speciﬁc editing. Individual offspring ﬂies were crossed to
CyO/Gla, Bc balancer ﬂies and the progeny was individually screened
for deletions in the DmAngel gene as followed. The wings of candidate
ﬂies were clipped and incubated at 37 °C for 45 min in freshly prepared
adult ﬂy homogenisation buffer (10 mM Tris-HCl, pH 8.2, 25 mM NaCl,
1 mM EDTA, 0,2 μg/μl proteinase K) and the homogenate was subsequently used for PCR screening and sequencing73. Successful DmAngelKO lines were backcrossed for 6 generations to a w;; background to
remove possible off-target effects.

(VDRC). Ubiquitous down-regulation was achieved by crossing the
UAS-RNAi lines to the driver daughterlessGAL4 (w;;daGAL4). Experimental samples are labelled as follows throughout the text: daGAL4
Control (w;;daGAL4/+, daGAL4 line crossed to w;;), RNAi Control
(w;UAS-RNAi/+;, RNAi line crossed to w;;), RNAi (w;UAS-RNAi/
+;daGAL4/+, RNAi line crossed to daGAL4).
All ﬂy stocks were backcrossed for at least 6 generations into the
Wolbachia-free white Dahomey background (w;;). All ﬂy lines were
maintained at 25 °C and 60% humidity on a 12 h:12 h light:dark cycle on
a standard yeast-sugar-agar medium.

Generation of genomic DmAngelrescue, DmAngelrescue-FLAG, and
DmAngelE121A ﬂies
The genomic DmAngel locus (6.5Kb from BAC clone CH322-6L23,
BACPAC Resource Centre, California, USA) was cloned by ET recombination into the pBluescript II SK + vector (Stratagene), modiﬁed for
FLAG tag addition or E121A mutation, and further subcloned into pattB
plasmid. Transgenic lines were generated via P-element-mediated
germ line transformation (BestGene Inc).

Generation of DmAngel, DmAngelFLAG, CG13850, and
CG13850FLAG overexpression ﬂy lines for immunoprecipitation
DmAngel and CG13850 cDNAs were PCR ampliﬁed with or without
an in frame STOP codon and ﬂanking attB sites for cloning into
pDONR201 (Thermo Fisher Scientiﬁc), before subcloning into
pTWF (Drosophila Genomics Resource Center), and ﬁnally into
pUASTattB with or without a FLAG tag at their 3′ ends. The overexpressing lines were generated via P-element-mediated germ line
transformation, by injecting pUASTattB-DmAngel, pUASTattBDmAngel-FLAG, pUASTattB-CG13850, or pUASTattB-CG13850-FLAG
plasmids into Drosophila embryos using BestGene Inc. Primers
used to generate the constructs are detailed in Supplementary
Data File 2.

Drosophila stocks and maintenance
For in vivo knockdown of CG13850 a w;UAS-CG13850RNAi; line
(#15233) was obtained from Vienna Drosophila Resource Center
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ANGEL2 knock out mice and mouse husbandry
Angel2 KO mice were obtained from Nanjing Biomedical Research
Institute, Nanjing University, China (Strain number: T001889; B6/NAngel2em1Cd32/Nju) and were backcrossed to the C57BL/6N strain
(Charles River Laboratories). Mice were housed in standard individually ventilated cages with a 12-h:12-h light:dark cycle under controlled
environmental conditions. Mice were fed ad libitum with standard
CRM mouse food (Special Diet Services). All animal procedures were
approved by the Stockholm’s Animal Experimentation Ethics Board
(Ethical permit number 14460/18) of the Swedish Board of Agriculture
and were performed in accordance with national and European law.
Genotyping primers of Angel2KO mice are detailed in Supplementary
Data File 2.

Cell culture, nucleofection and transduction
Immortalised human skin ﬁbroblasts (HSFs) were cultured in highglucose DMEM (Thermo Fisher Scientiﬁc) supplemented with 10%
foetal bovine serum (Thermo Fisher Scientiﬁc) at 37 °C in a 5% CO2
atmosphere. Experiments were performed with cells cultured to
80–90% conﬂuency. Medium was changed regularly, and cells were
passaged using TrypLE Express (Thermo Fisher Scientiﬁc).
To analyse subcellular localisation, the cDNA for human ANGEL1,
ANGEL2 and DmAngel were cloned into pDONR201 (Thermo Fisher
Scientiﬁc) and further subcloned into Gateway pcDNA-DEST47
(Thermo Fisher Scientiﬁc), that carries an in-frame GFP gene. Nucleofection of HSFs was performed using a 4D-Nucleofector System
(Lonza) and buffer P2, following manufacturer’s instructions. 48 h after
the nucleofection, ﬁbroblasts were processed for experiments.
Stable expression of human ANGEL1, ANGEL1-FLAG, ANGEL2 and
ANGEL2-protein C in immortalised HSFs was achieved by cloning into
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pBABE-Puro-gateway. For retroviral particle generation, PhoenixAMPHO cells were transfected with the pBABE constructs using Lipofectamine 3000 (Thermo Fisher Scientiﬁc) following manufacturer’s
instructions. Medium was harvested and ﬁltered 48 h after transfection. HSFs were transduced in a 50–50 mixture of fresh and retroviral
positive medium with 4 μg/ml polybrene (Merck). Puromycin selection
was initiated 48 h after transduction. Primers used to generate the
constructs are detailed in Supplementary Data File 2.

Immunostaining and confocal microscopy
Immortalised HSFs were cultured on 1.5 mm cover slips and ﬁxed for
20 min at room temperature using 3% paraformaldehyde. Permeabilisation and blocking was performed using a combination of 0.1%
saponin (Merck), 1% BSA (Merck) in PBS for 1 h. Primary antibody antiTOM20 (42406, Cell Signalling) was diluted 1:200 in PBS with 0.1%
saponine and 1% BSA and incubated overnight. After washing, cells
were incubated for 1 h with secondary antibody Alexa Fluor 568 (Goat
anti-Mouse IgG (H + L) antibody Alexa Fluor 568, A-11031, Thermo
Fisher, or Goat anti-Rabbit IgG (H + L) antibody Alexa Fluor 568, A11036, Thermo Fisher) at a 1:1000 dilution. Cells were mounted with
ProLong Gold Antifade Mountant and 0.01 μg/ml DAPI (Merck). Images were acquired using a Nikon Ti-E inverted point scanning confocal
microscope A1R Si.

Isolation of mitochondria from cell lines, mouse tissues and
Drosophila larvae
Immortalised HSFs were collected by scrapping from 8–12 p150 plates
and washed with PBS. The pellet was resuspended in mitochondrial
isolation buffer (220 mM mannitol, 70 mM sucrose, 1 mM EDTA,
20 mM HEPES pH 7.6) supplemented with 2 mg/ml of BSA and incubated on ice for 15 min. Cells were homogenised by hand with
20 strokes and centrifuged at 800 × g for 5 min at 4 °C. The supernatant was subsequently centrifuged at 10,000 × g for 10 min at 4 °C to
obtain the crude mitochondrial fraction.
Mitochondria were isolated from mouse tissues using differential
centrifugation as previously described74. Brieﬂy, fresh tissue was cut,
washed with PBS, and homogenised in a potter homogeniser. Heart
tissue was homogenised in 225 mM sucrose, 1 mM EGTA, 20 mM TrisHCl pH 7.2 and 200 μl of 2.5% trypsin. Liver was homogenised in
310 mM sucrose, 10 mM Tris-HCl, and 1 mM EDTA. The homogenates
were centrifuged at 1000 × g for 10 min at 4 °C to pellet nuclei and cell
debris and the supernatant was subsequently spun at 10,000 × g for
15 min at 4 °C to obtain the crude mitochondrial fraction.
Isolation of mitochondria from larvae was performed as previously described45. Third-instar larvae were washed and homogenised
in 250 mM sucrose, 2 mM EGTA and 5 mM Tris pH 7.4 with 1% BSA,
nuclei and cell debris were pelleted by centrifugation at 1000 × g for
5 min at 4 °C. The supernatant was centrifuged at 7000 × g for 10 min
at 4 °C to obtain the crude mitochondrial fraction.

Proteinase K protection assays
In total, 250 μg of Drosophila mitochondria were resuspended in 2 mM
Tris-HCl pH 7.4, 250 mM sucrose, 2 mM EGTA. Swelling was performed
by resuspension of 250 μg of mitochondria in 2 mM Tris-HCl pH 7.4,
2 mM EGTA and pipetting up and down. To disrupt mitochondrial
membranes, mitochondria were resuspended in 2 mM Tris-HCl pH 7.4,
250 mM sucrose, 2 mM EGTA and 0.3% Triton X-100. Digestion of
accessible proteins was achieved by addition of 31.5 μg/ml or 63 μg/ml
proteinase K and incubation for 20 min on ice. Digestion was stopped
by addition of a protease inhibitor cocktail. Proteins were pelleted with
sodium deoxycholate and TCA and loaded onto 4–12% SDS-PAGE gel
for western blot detection of mitochondrial proteins.
In total, 125 μg of HSF mitochondria were resuspended in 20 mM
HEPES pH 7.6, 220 mM mannitol, 70 mM sucrose, 1 mM EDTA. Swelling
of the mitochondrial membranes was achieved by resuspending
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mitochondria in 20 mM HEPES pH 7.6, 1 mM EDTA and pipetting up
and down 10 times. To disrupt mitochondrial membranes, mitochondria were resuspended in 20 mM HEPES pH 7.6, 220 mM mannitol,
70 mM sucrose, 1 mM EDTA and 0.3% Triton X-100. Digestion, precipitation, and detection of proteins was performed as
described above.

Alkaline carbonate extraction of mitochondrial membrane
proteins
In total, 125 μg of mitochondria were pelleted by centrifugation and
resuspended in 0.1 M Na2CO3 of the corresponding pH, pipetted up
and down and incubated on ice for 30 min. Samples were centrifuged
in a TLA55 rotor, at 45,000 × g for 30 min at 4 °C, to separate membrane associated proteins in the pellet and soluble proteins in the
supernatant. Proteins in each fraction were precipitated by sodium
deoxycholate and TCA and loaded onto 4–12% SDS-PAGE gel for western blot detection of mitochondrial proteins.

Western blotting
Mitochondria were resuspended in NuPAGE LDS sample buffer, loaded
on NuPAGE gels (Thermo Fisher Scientiﬁc) and transferred to PVDF
membranes (Millipore). Primary antibodies used in this study were
anti-DDDDK (ab1257, Abcam, 1:2000), ANGEL1 (sab1303061, Merck,
1:1000), Histone 3 (H0164, Merck, 1:2000), HSP60 (AB1-SPA-807-E,
Enzo Life Sciences, 1:1000), Protein C (A00637, GenScript, 1:1000),
TOM20 (13929S, Cell Signalling, 1:1000), AIF (ab16501, Chemicon,
1:1000), MRPS16 (HPA054538, Merck, 1:1000), MRPL12 (HPA022853,
Merck, 1:1000), TIM22 (14927-1-AP, Protein Tech, 1:1000), Porin
(ab128568, Abcam, 1:1000), GAPDH (ab8245, Abcam, 1:1000). Membranes were washed and incubated for 1 h at RT with the appropriate
secondary antibody at a 1:4000 dilution. Secondary antibodies used in
this study were horseradish peroxidase-conjugated anti-rabbit IgG
(NA9340-1ML, Cytiva), anti-mouse IgG (NA9310-1ML, Cytiva) or mouse
anti-goat IgG (#sc-2354, Santa Cruz Biotechnology). Western blots
were visualised using Clarity Western ECL solution (Bio-Rad), following
manufacturer’s instructions.

Blue native polyacrylamide gel electrophoresis (BN-PAGE) and
biochemical evaluation of respiratory chain function
BN-PAGE and in-gel staining for complex I, IV and V activities was
performed as previously described21. Mitochondria isolated from larvae or mouse tissues were resuspended in 250 mM sucrose, 15 mM
K2HPO4, 2 mM MgAc2, 0.5 mM EDTA and 0.5 g/l BSA, pH 7.2, and biochemical activities of the respiratory chain complexes were determined as previously described75.

RNA isolation, reverse transcription, and quantitative PCR
RNA was isolated using TRIzol (Thermo Fisher Scientiﬁc) and quantiﬁed with a Qubit ﬂuorometer (Thermo Fisher Scientiﬁc) unless
otherwise stated. Reverse transcription for qRT-PCR analysis was
performed using High-Capacity cDNA Reverse Transcription Kit
(Thermo Fisher Scientiﬁc). qRT-PCR was performed on a QuantStudio
6 (Thermo Fisher Scientiﬁc) with Taqman probes (Thermo Fisher Scientiﬁc) or Platinum SYBR Green qPCR supermix-UDG (Thermo Fisher
Scientiﬁc) and gene-speciﬁc primers. Primers and Taqman probes used
for qRT-PCR are detailed in Supplementary Data File 2.

Northern blot analysis of mitochondrial RNAs
Steady-state levels of mitochondrial transcripts were determined by
Northern blot analysis as previously described21. RNA samples were
separated in 1% MOPS-formaldehyde agarose gels and tRNAs were
separated by neutral 10% PAGE gels. After separation, samples were
transferred to Hybond-N + membranes (GE Healthcare) and hybridised
with randomly [32P]-labelled dsDNA probes, [32P]-labelled strandspeciﬁc RNA probes or with [32P]-end labelled oligonucleotide probes.
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Membranes were exposed to a PhosphorImager screen, and the signal
was quantiﬁed using a Typhoon FLA7000 system and ImageQuant TL
8.1 software (GE Healthcare). Primers used to generate dsDNA and oligonucleotide probes have been previously described45,76.

Mitochondrial poly(A) tail-length assay (MPAT)
MPAT was performed as previously described77. In brief, 0.2–2 μg of
total mouse or Drosophila RNA was ligated to a linker oligonucleotide
at the 3′ end using T4 RNA ligase 1 (New England Biolabs) or RtcB ligase
(New England Biolabs) and reverse transcribed using M-MLV reverse
transcriptase (Thermo Fisher Scientiﬁc) and an oligonucleotide complementary to the linker sequence. Poly(A) tails were PCR ampliﬁed
using a gene-speciﬁc forward primer and the anti-linker oligo, followed
by precipitation to remove oligonucleotides and free nucleotides.
Labelling was achieved with 5 cycles of a nested PCR on the initial PCR
product, using internal end-labelled gene speciﬁc oligonucleotides
and the anti-linker oligo. PCR products were separated on 6 or 8% high
resolution polyacrylamide gels and exposed to PhosphorImager
screens. Quick CIP (New England Biolabs) and T4 PNK (New England
Biolabs) treatment was performed according to manufacturer’s
recommendations, followed by puriﬁcation of the treated RNA using
acid phenol and precipitation with sodium acetate before the ligation
to the linker oligonucleotide. Oligonucleotide linker and primers used
for the MPAT assay are detailed in Supplementary Data File 2.

Cloning and puriﬁcation of DmANGEL, HsANGEL2 and
MmANGEL2
A codon-optimised (Genscript) DNA construct corresponding to
DmANGEL (amino acids 26–354) was cloned into a Pet24b vector and
HsANGEL2 (amino acids 165–544) or MmANGEL2 (amino acids
164–544) was cloned into a Fh8-Pet24d vector. HsANGEL2 and
MmANGEL2 were expressed in Arctic express cells (Agilent) at 16 °C for
48 h in Magic Media (Thermo Fisher Scientiﬁc). After lysis, the proteins
were puriﬁed over a His-Select Ni2+ resin (Sigma-Aldrich) and dialysed
against H-0.5 (25 mM Tris pH 7.4, 0.5 mM EDTA, 10% glycerol, 3 mM βmercaptoethanol, 500 mM NaCl) after the addition of TEV protease at
a 1:50 protease:protein ratio. The dialysed proteins were loaded on a
second Ni2+ resin for TEV protease removal and the ﬂow through was
collected. Further puriﬁcation was conducted over a HiLoad 16/60
Superdex 200 pg gel ﬁltration column (GE Healthcare) in buffer H-0.5
lacking glycerol with the addition of 2 mM dithiothreitol instead of
β-mercaptoethanol. DmANGEL was expressed and puriﬁed analogous
to HsANGEL2 except that no His tag removal was performed.

RNA synthesis
HsNd5, MmNd5 and Dmnd6 oligos with 2′-terminal phosphate groups
were prepared by RNA solid-phase synthesis with standard phosphoramidite methods on an H-8 DNA/RNA/LNA synthesiser (K&A
Laborgeräte).
5′-O-DMT/2′-O-TBDMS-protected 3′-β-cyanoethyl phosphoramidites of N6-benzoyladenosine, N4-acetylcytidine, N2-acetylguanosine and uridine were employed as 70 mM solutions in
anhydrous MeCN. The 3′-terminal nucleotide was incorporated using a
5′-O-DMT/3′-O-TBDMS-protected 2′-β-cyanoethyl phosphoramidite of
either N4-benzoylcytidine (HsND5) or N6-benzoyladenosine (MmNd5,
Dmnd6) dissolved in anhydrous MeCN at the same concentration.
Installation of 2′-terminal phosphate groups was achieved by using
phosphate CPG support (1 μmol). Coupling times were 6 min for
standard and 9 min for isomeric phosphoramidites, respectively, with
250 mM ETT in MeCN as the activator.
Cleavage from the solid support and removal of the base-labile
protecting was achieved by treatment with 25% aq. NH3/EtOH 3:1
(1.2 ml) at 55 °C for 4 h.
After lyophilisation, the residue was dissolved on anhydrous
DMSO (100 μl). 2′-O-silyl deprotection was performed by treatment
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with Et3N·3HF (125 μl) at 65 °C for 2.5 h, followed by addition of aq.
NaOAc (25 μl, 3 M, pH 6.5). The crude RNA was desalted by EtOH
precipitation and puriﬁed by preparative denaturing PAGE (20%). The
purity of the isolated RNA was conﬁrmed by analytical PAGE (20%) with
SYBR Gold staining.
Preparative denaturing polyacrylamide gels (0.7 × 200 × 200 mm)
were cast from 20% acrylamide/bis-acrylamide 19:1 and 8 M urea. Gels
were run for 2.5 h at 35 W constant power in 1x TBE. The RNA was
visualised by UV shadowing, extracted from the gel by crush-and-soak
into TEN buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 300 mM
NaCl) and recovered by EtOH precipitation.
Analytical denaturing polyacrylamide gels (0.75 × 100 × 80 mm)
of the same composition were run for 1 h at 350 V constant voltage in
1x TBE, stained with SYBR Gold for 5 min in 1x TBE and imaged on an
ImageQuant LAS 4000 (GE Healthcare).
Standard 5′-O-DMT/2’-O-TBDMS-protected 3′-β-cyanoethyl phosphoramidites were purchased from Sigma-Aldrich and ChemGenes.
Isomeric 5′-O-DMT/3′-O-TBDMS-protected 2′-β-cyanoethyl phosphoramidites were purchased from ChemGenes. Phosphate CPG support
(1000 Å) was purchased from Glen Research (USA). All other reagents
for solid-phase synthesis were purchased from Sigma-Aldrich. HPLC
puriﬁed oligonucleotides containing 2’,3’-cyclic phosphates or 3’
phosphates were purchased from ChemGenes and Merck, respectively. Primer sequences are detailed in Supplementary Data File 2.

In vitro phosphatase assay
Oligonucleotides were 5′ labelled using T4 PNK (3′ phosphatase minus)
(New England Biolabs) according to the manufacturer’s instructions. In
total, 200 fmol of labelled substrate were incubated in 100 mM Tris pH
7.5, 10 mM MgCl2, 10 mM DTT and 50 mM KCl with the indicated
amounts of recombinant DmAngel, MmANGEL2 or HsANGEL2 prepared in a buffer containing 25 mM Tris pH 7.4, 0.5 mM EDTA, 10%
glycerol, 3 mM β-mercaptoethanol and 500 mM NaCl. MmANGEL2 and
HsANGEL2 reactions were incubated at 37 °C and DmAngel reactions
were incubated at 30 °C for 30 min and stopped by the addition of an
equal volume of Gel Loading Buffer II (Thermo Fisher Scientiﬁc) and
incubation at 70 °C for 10 min. Samples were loaded in 20% polyacrylamide gels, exposed to PhosphorImager screens and scanned in a
Typhoon FLA7000 system. Quick CIP (New England Biolabs) and T4
PNK (New England Biolabs) control treatments were performed
according to manufacturer’s recommendations.

Immunoprecipitation of DmAngel-FLAG and CG13850-FLAG
For DmANGEL-FLAG immunoprecipitation, embryos expressing
DmANGEL or DmANGEL-FLAG were collected and transferred to vials
with normal or heavy lysine as described in ref. 78. After 7 days,
mitochondria were puriﬁed from larvae as described above. For
CG13850-FLAG immunoprecipitation, larvae expressing CG13850, or
CG13850-FLAG were grown in standard ﬂy food and collected for
mitochondria isolation 4 days after egg laying.
In total, 2 mg of mitochondria were lysed in 50 mM Tris-HCl pH
7.5, 150 mM NaCl, 6% digitonin with protease inhibitor cocktail
(Roche). Samples were centrifuged at 20,000 × g for 15 min at 4 °C and
the supernatant was incubated overnight with ANTI-FLAG M2 agarose
beads (Merck) with rotation. Beads were pelleted at 5000 x g for 30 s
and washed ﬁve times with 50 mM Tris-HCl pH 7.5, 150 mM NaCl. Beads
containing the heavy and light labelled samples were pooled for proteomic analysis.

In organello translation assays
Mitochondrial de novo translation was assayed as previously
described76. In brief, 0.5 mg of mitochondria were incubated in translation buffer (100 mM mannitol, 10 mM sodium succinate, 80 mM KCl,
5 mM MgCl2, 1 mM KH2PO4, 200 mM ATP, 5 mM GTP, 200 mM creatine
phosphate, 6 mM creatine kinase, 100 μg/ml cycloheximide, 25 mM
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Article
HEPES pH 7.4 and 60 μg/ml of every amino acid except methionine)
and 150 μCi of an 35S-labelled mix of methionine and cysteine, EXPRESS
protein labelling mix easy-tag (Perkin Elmer), for 1 h at 37 °C. After
labelling, equal amounts of total mitochondrial protein were separated
on 16% or 17% SDS-PAGE gels, followed by staining with 1 g/l Coomassie
Brilliant Blue in a 20% ethanol, 10% acetic acid solution. Gels were then
destained, dried and exposed to a PhosphorImager screen.

Sucrose gradient centrifugation analysis and ribosome proﬁling
Mitochondria from DmAngelKO larvae or MmANGEL2KO heart tissue
were washed in ribosome buffer (50 mM KCl, 10 mM MgCl2, 10 mM
Tris pH 7.4). In total, 0.5 mg of mitochondria were lysed in 100 mM
NH4Cl, 10 mM MgCl2, 1% Triton X-100, 30 mM Tris pH 7.6, and protease
inhibitor cocktail, followed by centrifugation at 8000 × g for 30 min at
4 °C to remove debris. The supernatant was loaded onto a 10–30%
sucrose gradient in 10 mM MgCl2, 100 mM NH4Cl, 30 mM Tris pH 7.4
with protease inhibitor cocktail and RNase inhibitors. Gradients were
centrifuged in a SWTi55 rotor at 39,000 × g for 3 h at 4 °C. Twenty
fractions were collected from each gradient. For western blot analysis,
proteins in each fraction were precipitated and loaded on 12%
polyacrylamide gels.
For ribosome proﬁling experiments, mitochondrial lysates were
treated with 200U of RNase T1 for 30 min at room temperature, centrifuged and applied to a 10–30% sucrose gradient as described above.
The monosome fractions were pooled and RNA was extracted using
Direct-zol RNA micro prep kit (Zymo Research) following manufacturer’s instructions and incorporating an on-column RNase-free
DNase digestion to remove DNA. RNA was dephosphorylated and
phosphorylated with T4 PNK. RNA sequencing libraries for ribosome
proﬁling were prepared using the Illumina Small RNA Sample Prep Kit,
with a size selection step for 15–90 nt RNAs. Initially, sequenced read
pairs
were
merged
with
BBMerge
(useoverlap = t
pﬁlter = 1 mininsert = 18 mininsert0 = 18 trimnonoverlapping = t)79 to
remove non- overlapping sequences and trimmed of remaining linker
sequence (AACTGTAGGCACCATCAAT) with BBDuk (ktrim = r mink = 4
k = 18 hdist = 1 tpe tbo) from the BBTools suite v38.79. Subtractive
alignment was performed against Drosophila ncRNA sequences
downloaded from Ensembl, including nuclear rRNA and tRNAs, with
Bowtie2 (–fr)80. Unmapped reads were mapped to the Drosophila
Ensembl v99 transcriptome sequences with Bowtie2 v2.4.1 (–verysensitive–norc), with mitochondrial sequences modiﬁed to more
accurately reﬂect the mature RNA transcripts present within the
mitochondrion. In short, the singular annotations for bicistronic
transcripts were merged (mt:atp8/mt:atp6 and mt:nd4/mt:nd4l); 5′ and
3′ UTRs were added to select transcripts based on the observed positions of 5′ ends and poly(A) tails in RNASeq data (mt:nd1, mt:nd3,
mt:nd5, mt:co3, mt:cytb); 30 nt poly(A) tails were added to the 3′ end of
each mRNA and the large mitochondrial rRNA; a 5′ G was added to
mt:tRNA:His-GTG and 3′ CCA added to all tRNAs to reﬂect the nontemplated additions added post-transcriptionally. Mitochondrial
mRNA coverage bedgraph ﬁles were generated with BEDTools81
v2.26.0 and normalised to total reads mapped to mitochondrial
transcripts.

Sample preparation for proteomic analysis
Proteomics analysis was performed essentially as previously
described63,82. Mouse heart tissue was homogenised in 8 M urea,
50 mM ammonium bicarbonate, and 400 μm LoBind silica beads followed by sonication. In total, 25 μg of protein were digested with
0.5 μg trypsin (Promega) for 16 h at 37 °C, followed by the addition of
2.5 μl formic acid. Samples were cleaned on a C18 Hypersep plate and
labelled with TMT-10plex reagents in random order, adding 100 μg
TMT-reagent in 30 μl dry acetonitrile (ACN) to each digested sample
resolubilised in 70 μl of 50 mM triethylammonium bicarbonate
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(TEAB), and incubating at room temperature (RT) for 2 h. The labelling
reaction was stopped for 15 min (RT) with 5% hydroxylamine before
pooling. In total, 22 μg were stage tipped and dried before resuspended in 20 μl of 0.1% formic acid and 2% ACN.
Fly mitochondria isolated as described above and lysed with 8 M
urea, 0.2% ProteaseMAX™ surfactant in 50 mM ammonium bicarbonate and sonicated. Proteins were reduced with dithiothreitol and
alkylated with iodoacetamide, followed by digestion with 1.5 μg of
trypsin for 16 h at 37 °C, and desalting and labelling as described above.
The TMT-labelled tryptic peptides were fractionated on an XBridge
C18 UPLC column (2.1 mm inner diameter × 250 mm, 2.5 μm particle
size, Waters), and proﬁled with a linear gradient of 5–60% 20 mM
ammonium hydroxide in ACN (pH 10.0) over 48 min (ﬂow rate of
200 μl/min). Fractions were collected at 30 s intervals into a 96-well
plate and combined in 12 samples concatenating 8–8 fractions representing peak peptide elution.
For SILAF-IPs, agarose beads were supplemented with 30 μl of 4 M
urea in 100 mM Tris-HCl, pH 7.5 and 1 μl of 0.5 μg/μl Lys-C and incubated at 27 °C for 30 min, before collection of the supernatant. The
beads were washed in 1 M Urea, 50 mM Tris-HCl pH 7.5, 1 mM DTT and
with 100 mM Tris-HCl pH 7.5 twice. Digestion in the eluent was continued over night at RT adding 1 μl of 0.5 μg/μl Lys-C with shaking at
400 rpm, while the agarose beads were supplemented with 50 μl of
100 mM Tris-HCl and further digested with 1 μl of 0.5 μg/μl Lys-C
overnight at RT with shaking at 400 rpm. Following over-night digestion at RT, the peptide solutions were alkylated with 0.6 M iodoacetamide in 50 mM of AmBic, pH 8 for 30 min in the dark. The digestion
was stopped with 10 μl of formic, cleaned on a C-18 HyperSep plate
(Thermo Scientiﬁc) and dried in a Speedvac. Label-free IPs were processed as SILAF-IPs, except for the addition of 0.5 μg trypsin overnight.

Liquid chromatography-tandem mass spectrometry data
acquisition
TMT-labelled peptides were reconstituted in solvent A and ~2 μg
samples (3/12 μl) injected on a 50 cm long EASY-Spray C18 column
(Thermo Fisher Scientiﬁc) connected to an Ultimate 3000 nanoUPLC
system (Thermo Fisher Scientiﬁc) using a 90 min long gradient: 4–26%
of solvent B (98% acetonitrile, 0.1% FA) in 90 min, 26–95% in 5 min, and
95% of solvent B for 5 min at a ﬂow rate of 300 nl/min. Mass spectra
were acquired on a Q Exactive HF hybrid quadrupole orbitrap mass
spectrometer (Thermo Fisher Scientiﬁc) ranging from m/z 375 to 1500
at a resolution of R = 120,000 (at m/z 200) targeting 5 × 106 ions for
maximum injection time of 80 ms, followed by data-dependent higherenergy collisional dissociation (HCD) fragmentations of precursor ions
with a charge state 2+ to 8+, using 45 s dynamic exclusion. The tandem
mass spectra of the top 18 precursor ions were acquired with a resolution of R = 60,000, targeting 2 × 105 ions for maximum injection
time of 54 ms, setting quadrupole isolation width to 1.4 Th and normalised collision energy to 33%.
SILAF IP peptides were reconstituted in 15 μl solvent A and 5 μl
injected on a 50 cm long EASY-Spray C18 column (Thermo Fisher Scientiﬁc) connected to an EASY-nLC 1000 HPLC system (Thermo Fisher
Scientiﬁc) using a 60 min long gradient: 4–25% of solvent B (98%
acetonitrile, 0.1% FA) in 50 min, 25–40% in 10 min, 40–95% in 3 min,
and 95% of solvent B for 5 min at a ﬂow rate of 300 nl/min. Mass spectra
were acquired on an Orbitrap Fusion Tribrid mass spectrometer
(Thermo Fisher Scientiﬁc) ranging from m/z 375 to 1500 at a resolution
of R = 120,000 (at m/z 200) targeting 4 × 105 ions for maximum
injection time of 50 ms, followed by data-dependent HCD fragmentations of precursor ions with a charge state 2+ to 7+, using 30 s dynamic
exclusion. The tandem mass spectra were acquired with a resolution of
R = 30,000 in 2 s cycle time, targeting 5 × 104 ions for maximum
injection time of 100 ms, setting quadrupole isolation width to 1.6 Th
and normalised collision energy to 30%.
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Label-free IP peptides were measured as TMT-labelled peptides,
except for 30 s dynamic exclusion and a normalised collision
energy of 28%.

10.

Proteomics data analysis

11.

TMT proteomics data were mapped with Proteome Discoverer software (Thermo Fisher Scientiﬁc) version 2.5 against a UniProt D. melanogaster (downloaded October 2019 with 13,788 entries) and Mus
musculus canonical database at default settings. SILAF proteomics data
was mapped in MaxQuant v.1.6.3.483 at default settings with Lys0 or
Lys6 as labels and LysC/P as protease against the canonical and isoform
sequences of the fruit ﬂy proteome (UP000000803_7227 from UniProt, downloaded in September 2018 with 21,939 entries). Normalised
expression values, or normalised heavy/light ratios were further analysed in R v4.1.1. DmAngel knock-out ﬂy proteomic data on fractionated mitochondria was normalised to median intensities of
mitochondrial proteins to account for differences in organellar
enrichment. A limma moderated t-test was applied for statistical testing. MitoXplorer v284 protein sets were used as an annotated mitochondrial protein library. OXPHOS complex annotations were
manually curated in-house. Proteomics data have been deposited to
the ProteomeXchange85 Consortium.

9.

12.

13.

14.
15.

16.

17.

Reporting summary
Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

18.

Data availability
The data that support this study are available from the corresponding
authors upon reasonable request. The ribo-proﬁle data sets generated
in this study have been deposited to GEO with accession number
GSE189750. MS proteomics data generated in this study have been
deposited to the ProteomeXchange Consortium via the PRIDE86 partner repository with the dataset identiﬁer PXD033394. Datasets used in
this study are MitoXplorer v2, FASTA ﬁles from UniProt (D. melanogaster in October 2019, M. musculus in September 2018) and Drosophila Ensembl v99 transcriptome sequences. Source data are provided
with this paper.
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